eltromag

Introduction to eltromag

Eltromag is a medication primarily used to treat low platelet counts in conditions such as chronic immune thrombocytopenia and in patients with hepatitis C. Eltromag is available in tablet form and works by stimulating the production of platelets, which are essential for blood clotting.

Composition of eltromag

Eltromag contains the active ingredient eltrombopag, which is a thrombopoietin receptor agonist. This compound stimulates the bone marrow to produce more platelets, thereby helping to manage low platelet counts.

Uses of eltromag

• Treatment of chronic immune thrombocytopenia
• Management of low platelet counts in patients with hepatitis C

Side effects of eltromag

• Common side effects: nausea, headache, fatigue
• Serious side effects: liver problems, increased risk of blood clots

Precautions of eltromag

Regular liver function tests are necessary while taking eltromag due to the risk of liver problems. Patients should also be aware of the increased risk of blood clots and report any unusual symptoms to their healthcare provider.

How to Take eltromag

Eltromag is typically taken as a tablet. The usual starting dose for adults is 50 mg once daily, taken on an empty stomach, either one hour before or two hours after a meal. The maximum recommended dose is 75 mg per day. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of eltromag

Eltromag, containing the active ingredient eltrombopag, is a thrombopoietin receptor agonist used to treat low platelet counts in specific medical conditions. It is manufactured in tablet form and is essential for managing conditions like chronic immune thrombocytopenia and low platelet counts in hepatitis C patients. Regular monitoring and adherence to prescribed dosages are crucial for effective treatment. Eltromag plays a vital role in reducing the risk of bleeding by increasing platelet production.